Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA-Reference-Cited by-同舟云学术

Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA

Published:1997-11 Issue:3 Volume:29 Page:173-186
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Ballow Charles H.,Jones Ronald N.,Johnson David M.,Deinhart June A.,Schentag Jerome J.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference39 articles.

1. In vitro activities of 22 β-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood;Alcaide;Antimicrob Agents Chemother,1995

2. Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A double-blind, randomized, parallel, multicentre study;Allegra;J Antimicrob Chemother,1996

3. Sparfloxacin for the treatment of community-acquired pneumonia: A pooled data analysis of two studies;Aubier;J Antimicrob Chemother,1996

4. In vitro activity of sparfloxacin in comparison with currently available antimicrobials against respiratory tract pathogens;Baquero;J Antimicrob Chemother,1996

5. Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA;Barry;J Antimicrob Chemother,1997

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrocyclic-based strategy in drug design: From lab to the clinic;European Journal of Medicinal Chemistry;2024-11

2. Activity In Vitro of the Quinolones;Quinolone Antimicrobial Agents;2014-04-08

3. Increasing quinolone resistance and multidrug resistant isolates among Salmonella enterica in Hong Kong;Journal of Infection;2012-12

4. Characterization of fluoroquinolone-resistant β-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: Report from the SENTRY Antimicrobial Surveillance Program (1997–2004);Diagnostic Microbiology and Infectious Disease;2006-06

5. Current Perspectives on Streptococcus pneumoniae Antibiotic Resistance, With Particular Reference to Isolates From Spain;Clinical Pulmonary Medicine;2005-07